Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer—A Nationwide Cohort Study

SIMPLE SUMMARY: Immune checkpoint inhibitors are increasingly being used for treating advanced malignant cutaneous melanoma and lung cancer. Immune-related side effects in multiple organs are common but the frequencies of ophthalmic side effects in national cohorts of unselected patients are undescr...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Souza, Maria, Bagger, Mette, Alberti, Mark, Malmborg, Morten, Schou, Morten, Torp-Pedersen, Christian, Gislason, Gunnar, Svane, Inge Marie, Kiilgaard, Jens Folke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750081/
https://www.ncbi.nlm.nih.gov/pubmed/35008211
http://dx.doi.org/10.3390/cancers14010049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750081/
https://www.ncbi.nlm.nih.gov/pubmed/35008211
http://dx.doi.org/10.3390/cancers14010049

Ejemplares similares